On September 3, 2020 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer, and other indications, reported that members of the management team will participate in the following upcoming investor conferences and will provide a corporate update (Press release, Pieris Pharmaceuticals, SEP 3, 2020, View Source [SID1234564404]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Baird 2020 Virtual Global Healthcare Conference
Wednesday, September 9, 2019 at 11:25AM EDT
H.C. Wainwright 22nd Annual Global Investment Conference
Wednesday, September 16, 2019 at 2:00PM EDT
Additional information regarding these events will be available on the Company’s website at www.pieris.com.